Related references
Note: Only part of the references are listed.Secondary Failure of Metformin Monotherapy in Clinical Practice
Jonathan B. Brown et al.
DIABETES CARE (2010)
Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model
P. McEwan et al.
DIABETES OBESITY & METABOLISM (2010)
The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK*
C. L. Morgan et al.
DIABETIC MEDICINE (2010)
Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008*
C. J. Currie et al.
DIABETIC MEDICINE (2010)
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Craig J. Currie et al.
LANCET (2010)
Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Matthew P. Gilbert et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)
Helen L. Lutgers et al.
PLOS ONE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management(RECAP-DM) Study
F. Alvarez Guisasola et al.
DIABETES OBESITY & METABOLISM (2008)
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
S. R. Heller et al.
DIABETOLOGIA (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss
R Rowe et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Weight gain during insulin therapy in patients with type 2 diabetes mellitus
S Heller
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death - A population-based study of 13000 men and women with 20 years of follow-up
T Almdal et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Sulfonylurea inadequacy - Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
A Wright et al.
DIABETES CARE (2002)
Share Paper
